MedTrace Logo

The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms

NCT03089632 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-12-20

No results posted yet for this study

Summary

Patients with type-1 diabetes are more susceptible to motility-related upper gastrointestinal symptoms. Dietary interventions are one of the treatment pillars for these symptoms. Many gastrointestinal conditions other than celiac disease, are being increasingly treated with gluten-free diet (GFD). The role of GFD in non-celiac type-1 diabetic patients with dyspepsia-like symptoms has not been assessed before. In this study, type 1 diabetes patients with concomitant upper gastrointestinal symptoms will be asked to follow a 1-month GFD to assess changes in upper gastrointestinal symptoms and gastroduodenal motility before and after the dietary intervention.

Conditions

  • Diabetes Mellitus, Type 1
  • Gastroparesis
  • Dyspepsia
  • Gluten Sensitivity

Interventions

OTHER

Gluten-free diet

One-month gluten-free diet

Sponsors & Collaborators

Principal Investigators

  • Premysl Bercik, MD, PhD · McMaster University, Department of Medicine, Division of Gastroenterology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2018-06-01
Completion
2018-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089632 on ClinicalTrials.gov